Sartorius AG (SRT):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Sartorius AG (SRT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9923
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:55
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sartorius AG (Sartorius) manufactures and distributes laboratory and process technology equipment. The company’s lab products portfolio includes laboratory instruments, such as pipettes, laboratory water purification systems, weight sets and lab balances. It provides bioprocess solutions for efficient biologic manufacture of medications and vaccines. Sartorius also offers wide range of products for purification, separation and concentration, and solutions for storage and transportation of intermediate and final biological products. The company serves pharmaceutical, biotechnology, chemical, food and beverage industries, and numerous research and educational institutes and laboratories in Germany and across the world. It has manufacturing facilities in Europe, Asia and America. Sartorius is headquartered in Goettingen, Niedersachsen, Germany.

Sartorius AG (SRT) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Sartorius AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Sartorius AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Sartorius AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Sartorius AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Sartorius AG, Medical Devices Deals, 2012 to YTD 2018 10
Sartorius AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Sartorius AG, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
ViroCyt Raises USD4 Million in Venture Financing 12
ViroCyt Raises USD3.5 Million in Venture Financing 13
IntelliCyt Raises USD0.05 Million in Venture Financing 14
ViroCyt Raises US$3.5 Million In Series A Financing 15
ViroCyt Raises US$2.6 Million In Series B Financing 16
Private Equity 17
SFW Capital Partners Invests In Essen BioScience 17
Partnerships 18
Quad Technologies Enters into Partnership with Sartorius Stedim Biotech 18
IntelliCyt Partners with SpectraGenetics 19
Genedata Enters into Integration Agreement with IntelliCyt 20
Sartorius Stedim Biotech Enters Into Co-Development Agreement With BD Diagnostic 21
ProMetic Life Sciences Enters Into Co-Marketing Agreement With Sartorius Stedim Biotech 22
Sartorius Stedim Biotech Enters Into Agreement With c-LEcta 23
Sartorius Stedim Biotech Enters Into Co-Development With Refine Technology 24
Acquisition 25
Sartorius Acquires Essen BioScience for USD320 Million 25
Sartorius Stedim Biotech Acquires Cellca 26
Sartorius Stedim Biotech Acquires BioOutsource 27
Sartorius Stedim Biotech Acquires TAP Biosystems for USD44.7 Million 28
Sartorius AG – Key Competitors 29
Sartorius AG – Key Employees 30
Sartorius AG – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 34
Financial Announcements 34
Jul 24, 2018: Business Figures for the First Half of 2018: Sartorius Records Double-Digit Sales Growth 34
Apr 24, 2018: First-Quarter Figures: Sartorius Starts off Fiscal 2018 Successfully 36
Jan 31, 2018: Sartorius grows significantly again in sales revenue and earnings in 2017 – positive outlook for 2018 38
Oct 25, 2017: Nine-Month Figures for 2017: Sartorius Continues to Grow Profitably in a Challenging Environment 40
Jul 21, 2017: Business Figures for the First Half of 2017: Sartorius Continues to Grow 42
Jul 21, 2017: Solid growth at Sartorius Stedim Biotech; profits continue to rise 44
Apr 24, 2017: First-quarter figures: Sartorius starts off 2017 with double-digit growth 45
Feb 23, 2017: Sartorius Reviews Fiscal 2016 46
Jan 30, 2017: Sartorius Grows by Double Digits in Sales Revenue and Earnings in 2016 – Positive Outlook for 2017 48
Corporate Communications 50
Feb 21, 2017: Resolutions of the Sartorius Supervisory Board 50
Government and Public Interest 51
Nov 29, 2017: Second Sartorius Research Xchange Forum Focuses on Regenerative Medicine and Cell Therapy 51
Other Significant Developments 52
Oct 02, 2018: Genedata Bioprocess Offers Out-of-the-Box Integration with ambr Bioreactors 52
Oct 16, 2017: Sartorius Group: Key Figures on 9-Month Business Development in 2017 53
May 04, 2017: Sartorius Stedim Biotech Launches Chemistry Testing Services 54
Appendix 55
Methodology 55
About GlobalData 55
Contact Us 55
Disclaimer 55

List of Tables
Sartorius AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Sartorius AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Sartorius AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Sartorius AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Sartorius AG, Deals By Therapy Area, 2012 to YTD 2018 9
Sartorius AG, Medical Devices Deals, 2012 to YTD 2018 10
Sartorius AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
ViroCyt Raises USD4 Million in Venture Financing 12
ViroCyt Raises USD3.5 Million in Venture Financing 13
IntelliCyt Raises USD0.05 Million in Venture Financing 14
ViroCyt Raises US$3.5 Million In Series A Financing 15
ViroCyt Raises US$2.6 Million In Series B Financing 16
SFW Capital Partners Invests In Essen BioScience 17
Quad Technologies Enters into Partnership with Sartorius Stedim Biotech 18
IntelliCyt Partners with SpectraGenetics 19
Genedata Enters into Integration Agreement with IntelliCyt 20
Sartorius Stedim Biotech Enters Into Co-Development Agreement With BD Diagnostic 21
ProMetic Life Sciences Enters Into Co-Marketing Agreement With Sartorius Stedim Biotech 22
Sartorius Stedim Biotech Enters Into Agreement With c-LEcta 23
Sartorius Stedim Biotech Enters Into Co-Development With Refine Technology 24
Sartorius Acquires Essen BioScience for USD320 Million 25
Sartorius Stedim Biotech Acquires Cellca 26
Sartorius Stedim Biotech Acquires BioOutsource 27
Sartorius Stedim Biotech Acquires TAP Biosystems for USD44.7 Million 28
Sartorius AG, Key Competitors 29
Sartorius AG, Key Employees 30
Sartorius AG, Other Locations 31
Sartorius AG, Subsidiaries 31

List of Figures
Sartorius AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sartorius AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sartorius AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sartorius AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sartorius AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Sartorius AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Sartorius AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Sartorius AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Sartorius AG, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Sartorius AG (SRT):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Storz Medical AG:企業の戦略的SWOT分析
    Storz Medical AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Jardine Matheson Holdings Ltd:企業の戦略・SWOT・財務分析
    Jardine Matheson Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Jardine Matheson Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Real Matters Inc (REAL):企業の財務・戦略的SWOT分析
    Real Matters Inc (REAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Franchise Services of North America Inc:戦略・SWOT・企業財務分析
    Franchise Services of North America Inc - Strategy, SWOT and Corporate Finance Report Summary Franchise Services of North America Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • The Avascent Group:企業の戦略・SWOT・財務情報
    The Avascent Group - Strategy, SWOT and Corporate Finance Report Summary The Avascent Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Bullfrog Power Inc.-エネルギー分野:企業M&A・提携分析
    Summary Bullfrog Power Inc. (Bullfrog Power) is a provider of green energy. The company offers renewable energy solutions that help businesses and houses in reducing their environmental impact. Bullfrog's product portfolio includes green electricity, green fuel and green natural gas. The company, th …
  • Hindustan Tin Works Limited:企業の戦略・SWOT・財務情報
    Hindustan Tin Works Limited - Strategy, SWOT and Corporate Finance Report Summary Hindustan Tin Works Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • IV Diagnostics Inc-医療機器分野:企業M&A・提携分析
    Summary IV Diagnostics Inc (IV Diagnostics) is a biomedical company that offers research services. The company conducts molecular diagnostic tests for circulating tumor cells and other blood borne diseases. It develops, tests and markets diagnostic tools that monitor and measure cancer tumor cells. …
  • Comrod Communication ASA:企業の戦略・SWOT・財務情報
    Comrod Communication ASA - Strategy, SWOT and Corporate Finance Report Summary Comrod Communication ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Gujarat State Electricity Corp Ltd:企業の戦略的SWOT分析
    Gujarat State Electricity Corp Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Sumitomo Precision Products Co Ltd:企業の戦略・SWOT・財務分析
    Sumitomo Precision Products Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Precision Products Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • The Mediterranean & Gulf Cooperative Insurance & Reinsurance Company (S.J.S.C):企業の戦略・SWOT・財務情報
    The Mediterranean & Gulf Cooperative Insurance & Reinsurance Company (S.J.S.C) - Strategy, SWOT and Corporate Finance Report Summary The Mediterranean & Gulf Cooperative Insurance & Reinsurance Company (S.J.S.C) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data …
  • Schneider Electric SE (SU):企業の財務・戦略的SWOT分析
    Schneider Electric SE (SU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • TTM Technologies, Inc.:企業の戦略・SWOT・財務情報
    TTM Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary TTM Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Packages Limited:企業の戦略・SWOT・財務情報
    Packages Limited - Strategy, SWOT and Corporate Finance Report Summary Packages Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Coastal Contacts Inc-医療機器分野:企業M&A・提携分析
    Summary Coastal Contacts Inc (Coastal Contacts), a subsidiary of Essilor International is an online retailer that markets eye care products. The company's products include eyeglasses, contact lenses, sunglasses, vision care accessories, and others. Its contact lenses comprise daily wear colour lense …
  • Clark Public Utilities:企業の戦略的SWOT分析
    Clark Public Utilities - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Burmeister & Wain Scandinavian Contractor AS-エネルギー分野:企業M&A・提携分析
    Summary Burmeister & Wain Scandinavian Contractor A/S (BWSC), a subsidiary of MESCO Denmark A/S, is a provider of tailor-made turnkey power plant solutions. It develops, operates and undertakes contracts for medium to large-scale power plants. The company handles projects for conventional fossil-fue …
  • Mars Incorporated:企業の戦略的SWOT分析
    Mars Incorporated - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Nationwide Financial Services, Inc.:企業の戦略的SWOT分析
    Nationwide Financial Services, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆